logo
科言猫学术研究的AI总结
language
手机端手机端
  • Phone Feature微信小程序
简体中文简体中文
notice消息通知
博客博客
arrow
M

Miloš D. Miljković

Hospital Clínic de Barcelona
H指数:35
被引数:4,866

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

A phase 1 trial of romidepsin, azacitidine, dexamethasone and lenalidomide in relapsed or refractory T-cell lymphoma

一項关于romidepsin、azacitidine、dexamethasone和lenalidomide在复发或难治性T细胞淋巴瘤中的1期临床试验

Blood Advances
IF7.1
2026-02-160
OAAI
Max J. Gordon; Milos D. Miljkovic; Paige Milhon; Rahul Lakhotia; Christopher Melani; Kim Johnson; Bonita Bryant; Stefania Pittaluga; Elaine S. Jaffe; Kevin Conlon; Louis M. Staudt; Wyndham H. Wilson; Mark Roschewski; Samuel Ng
BCMA-directed mRNA CAR-T cell therapy for myasthenia gravis: exploratory biomarker analysis of a placebo-controlled phase 2b trial

BCMA指导的mRNA car-t细胞治疗重症肌无力: 一项安慰剂对照2b期试验的探索性生物标志物分析

Nature Medicine
IF50
2026-01-090
OAAI
Renee R. Fedak; Rachel N. Ruggerie; Yufei Shan; Elizabeth J. Curvino; Juliana F. de Sousa; Shaji Daniel; Minhtran Ngo-Casi; Hafsa Kamboh; Tuan Vu; Hacer Durmuş; Tahseen Mozaffar; James F. Howard; Emily P. English; Albina Benson; Matthew T. Duvernay; Michael S. Singer; Murat V. Kalayoglu; Carsten Brunn; Aaron Bodansky; Mark S. Anderson; Joseph L. DeRisi; Samantha T. Garcia; David J. L. Yu; Kelsey C. Zorn; Metin Kurtoglu; Miloš D. Miljković; C. Andrew Stewart; Christopher M. Jewell
BCMA-directed mRNA CAR T cell therapy for myasthenia gravis: a randomized, double-blind, placebo-controlled phase 2b trial

BCMA指导的mRNA CAR T细胞治疗重症肌无力: 一项随机，双盲，安慰剂对照的2b期试验

Nature Medicine
IF50
2026-01-090
OAAI
Tuan Vu; Hacer Durmus; Michael Rivner; Sheetal Shroff; Thomas Ragole; Bennett Myers; Mamatha Pasnoor; George Small; Chafic Karam; Mithila Vullaganti; Amanda Peltier; Gregory Sahagian; Marc H. Feinberg; Adam Slanksy; Carolina Barnett-Tapia; Zaeem Siddiqi; Kelly Gwathmey; Michael A. Badruddoja; Hafsa Kamboh; Rachel N. Ruggerie; Renee R. Fedak; C. Andrew Stewart; Metin Kurtoglu; Murat Kalayoglu; Michael Singer; Christopher M. Jewell; Milos D. Miljkovic; Mazen Dimachkie; Tahseen Mozaffar; James F. Howard
mRNA engineering of allogeneic mesenchymal stem cells enables coordinated delivery of T cell engagers and immunotherapeutic cues

同种异体间充质干细胞（allogeneic mesenchymal stem cells）的mRNA工程化改造，能够协同递送T细胞结合器（T cell engagers）和免疫治疗信号（immunotherapeutic cues）。

Nature Biomedical Engineering
IF26.6
2025-11-280
PRE
C. Andrew Stewart; Shaji Daniel; Elizabeth J. Curvino; Yi Zhang; Hafsa Kamboh; Kirill Sergueev; Minhtran N. Casi; Adam Chowdhury; Heng Xu; Youqiang Li; Mehmet Tosun; Matthew T. Duvernay; Yufei Shan; Mame Djigal; Maria Kireeva; Jennifer L. Biaksangi; Taylor Glassband; Fevzi Altuntas; Tuğçe Nur Yiğenoğlu; Ralph Boccia; Jesus Bardeja; Tamna Wangjam; Michael S. Singer; Murat V. Kalayoglu; Metin Kurtoglu; Albina Benson; Emily P. English; Lisa H. Tostanoski; Milos D. Miljkovic; Christopher M. Jewell

研究方向

暂未获取到该数据
M
Max Diem
H 指数:57论文数:257被引数:9,713
B
Benjamin Bird
H 指数:26论文数:52被引数:3,164
M
Marc Sorigué
H 指数:15论文数:178被引数:952
M
Melissa Romeo
H 指数:24论文数:59被引数:2,362
J
James F. Howard
H 指数:56论文数:379被引数:1.3万
C
Christopher M. Jewell
H 指数:47论文数:209被引数:8,701
A
Antonella I. Mazur
H 指数:9论文数:21被引数:516
C
Christian Matthäus
H 指数:34论文数:124被引数:4,136
S
Stefania Pittaluga
H 指数:116论文数:785被引数:4.5万
N
Nora Laver
H 指数:30论文数:110被引数:2,680